Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Columbia University, Herbert Irving Comprehensive Cancer Center, New York

Fox Chase Cancer Center, Philadelphia

Duke University Medical Center, Durham

University of Chicago, Chicago

Washington University, Alvin J. Siteman Cancer Center, St Louis

University of Texas, MD Anderson Cancer Center, Houston

Huntsman Cancer Institute, Salt Lake City

City of Hope, Duarte

UC San Diego, San Diego

UC Irvine Medical Center, Orange

Seattle Cancer Care Alliance, Seattle

Dana-Farber Cancer Institute, Boston

Cross Cancer Institute, Edmonton

British Columbia Cancer Agency, Vancouver Center, Vancouver

Jewish General Hospital, Montreal

National Cancer Center, Gyeonggi-do

Seoul National University Hosptial, Seoul

Samsung Medical Center, Seoul

Yonsei University Health System, Severance Hospital, Seoul